Top rare disease therapeutic companies enterprise value worldwide 2000-2017

This statistic shows the total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017, sorted by oncology and non-oncology companies. In 2016, the value of all non-oncology rare disease therapeutic companies combined was some 252 billion U.S. dollars.

Total enterprise value of top rare disease therapeutic companies worldwide from 2000 to 2017 (in million U.S. dollars)*

Non-OncologyOncology
200030,7256,619
200547,9296,728
201081,69827,909
2015311,493132,310
2016252,231115,595
2017*315,681193,116
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2017

Region

Worldwide

Survey time period

2000 to 2017

Method of interview

Online survey

Supplementary notes

* As of October. The statistic includes the top 31 pure play rare disease therapeutic companies.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.